Short sellers are not the only folks nervous about a $DUSS

New Post Public Reply Private Reply Replies (1) Message Board
MicroCapStocksRock Tmoney #2396
Short sellers are not the only folks nervous about a $DUSS Merger and huge buying spree. Check out this info. 100% on topic.

A Short Seller Manipulation Technique Used by OTC Market Makers.
I know so many of us on here want answers to so many questions we have, I hope this helps clarify some of those questions. Enjoy!

In the stock market, price is the best advertising.

A stock that is going up tends to create the belief that it will continue to go up, and thus demand is created.

Price gets attention. We see the change in price and the price chart as a guides for action.

Short squeezes – buying panics – are created by rapid upward price movement and so feed on themselves.

Now, if I told you that I, as a market maker, could drop the stock price in the face of consistent buying and so go short and create panic selling, you might find this to be new and rather electrifying information would you not? That’s why you are reading. (P.S - This is pretend - I am not a MM)


Here is the simple and little known trick of market makers.

We start with the inside bid ask of the stock, let’s give a hypothetical market, $0.20 bid offered at $0.26, with the last sale being at $0.26.

Now of course this is not a real stock and I am not going to give you real history. Any close similarity between this delusional and fictional narrative and exactly what happened to a certain stock – yesterday – is simply a matter of total coincidence despite your swinish suspicions to the contrary.

A buy order for 10,000 is entered and instead of being executed at 0.26, the market makers made the sale at 0.259, so that the buy order actually dropped the price compared with the last sale of 0.26 – so the stock shows 10,000 shares traded on a down move – making the buy look like a sale.

About 10 minutes passes, and another buy order, this time for 20,000 shares is entered and that is executed at 0.258 – another down tick on another buy order!

So now the stock is down on 30,000 shares of buying only – no selling.


Folks, that is not normal supply and demand, is it? You would expect that on buy orders the stock would go up or at least stay the same, would you not?



Silly you.

If the market maker now goes and hits the bid of his competition, even for a small amount of stock, let us say 1,000 shares, the last sale is showing is now 0.20 and the stock is down 23% on heavy buying of 30,000 shares, but it looks like the stock is being dumped in a panic.

What is the effect of this false appearance on the market?

First, they buyers apparently have an immediate loss of 23%. Second, anyone with a buy order may hold off on buying to see where the stock stabilizes. If the company is trying to get people to buy the stock, as it has a right to do, it is going to be much harder to whip up enthusiasm as the stock looks like it is crashing.

Sellers, if they panic, will now come in and sell. In fact, the stock could be so demoralized that, hypothetically speaking, it could close at 0.14, down 46%, but again, this is only fictional, right?

Now if we were to check OTCShorteport.com to see what the volume of trading vs short selling looked like, we might find that half of the volume was short selling, theoretically speaking, of course. Presumably this would be by the market makers going short at 0.259 and 0.258 and elsewhere to push the price down. We would also find that half of the selling might be from long sellers who went into a panic, perhaps maybe.

Now again, all this is a merely fictional example, and I would never accuse my fellow market makers of doing anything this destructive just to make a fast buck. But it is the type of thing that I now get paid the big bucks to discover and combat.

Why? Consider what this means to the company. If the company had a $100 million market capitalization, reducing the price by 46% is a $46 million loss for the shareholders on a day when there was really nothing but buying in the stock.

If the company is selling stock to raise money, say $10 million, it means that it has to now pay stock with a value of $14.6 million to get the same money – a loss of $4.6 million.

And if the shorts are short ten million shares, they made 0.26 minus 0.14 or 0.12 per share or only $1,200,000 while the shareholders had a $46 million paper loss.

Prospect Ventures, Inc. (IVAP) Stock Research Links

IVAP Board Company Profile Buy Rating Time & Sales News Filings Financials
My Favorite plays are on the Nasdaq DIP and RIP Board http://investorshangout.com/NASDAQ-DIP-and-RIP-87909/
My Favorite Paid chat room with amazing chart setups is The Trading Stock Lounge http://www.thetradingstocklounge.com/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

HVAC’s $383.6 Billion Shift Is About More Than Units

Updated Category News Views 163

Server racks are turning cooling gear into a front-row industrial story, and that deserves more attention than the usual sleepy talk about replacement air conditioners. Frost & Sullivan projects the global HVAC equipment market will reach $383.6 billion by 2031, growing at a 7.0% compound annual rate from 2025. That is a sizable market, sure, but the more interesting...

Continue Reading
PAG, HOWL and PSNL Deals Face Fresh Shareholder Checks

Updated Category News Views 38

Three proposed takeovers, three very different headaches, and one familiar question that never gets old: are regular shareholders actually receiving the best available deal? On Nov. 20, 2026, investor-rights law firm Halper Sadeh LLC said it was investigating the proposed transactions involving Penske Automotive Group, Werewolf Therapeutics and Personalis for potential...

Continue Reading
Why Dent Repair Estimates Need More Than a Simple Ruler

Updated Category News Views 60

A dent can look harmless in a parking-lot glare and still turn into a stubborn repair job once somebody examines the metal properly. That is the useful, unglamorous point Jason Phelps of Magic Dent makes in a HelloNation article: visible diameter is not a verdict. Anybody shopping for vehicle repairs, managing fleet costs, or watching the collision-service ecosystem ought...

Continue Reading
NetEase Miss Opens an Investigation, Not a Verdict

Updated Category News Views 132

A two-dollar earnings gap can make a shareholder base jumpy fast, and NetEase just handed the market a rough set of numbers to chew on. The November 19 notice says NetEase's third-quarter 2026 report missed Wall Street expectations on both earnings and revenue, followed by a sharp decline in the shares. That has prompted SueWallSt, powered by Levi & Korsinsky LLP, to...

Continue Reading
RBI Heads to Morgan Stanley With Plenty to Explain

Updated Category News Views 63

Two executives, one New York stage, and a short calendar gap give Restaurant Brands International a clean chance to address investors without the usual blizzard of quarterly slides. Chief Executive Officer Josh Kobza and Chief Financial Officer Sami Siddiqui are scheduled for a fireside chat at Morgan Stanley's Global Consumer & Retail Conference on December 2, 2026, at...

Continue Reading
Cirrus CEO Takes SIA Chair as Chip Policy Heats Up

Updated Category News Views 196

A trade-group gavel rarely moves a stock by itself, but this one lands in a noisy part of the chip cycle. On November 19, 2026, the Semiconductor Industry Association elected Cirrus Logic President and CEO John Forsyth as chair of its board. That is not a revenue announcement, not a factory groundbreaking, and certainly not a reason to start flinging confetti at...

Continue Reading
COP31 Tests Whether Climate Warnings Move Power Systems

Updated Category News Views 101

A weather alert that never reaches the control room is just expensive wallpaper. That was the useful, unsentimental thread running through a COP31 side event in Ankara on November 13: climate diplomacy is not worth much if grid operators, project owners and financiers do not change what they do when the forecast turns ugly. Implementation Means Changing Operations COP31...

Continue Reading
Dario's Personify Panel Puts Distribution Model in Focus

Updated Category News Views 208

A Partner Megaphone Is Not a Revenue Line Monday's virtual panel gives DarioHealth a useful stage, but investors should not confuse a conference microphone with a signed sales order. Erez Raphael is set to lead a November 23 discussion with Personify Health President Ed Liebowitz at the U.S. Bancorp | BTIG Tech-Enabled Healthcare Forum, running from noon to 12:50 p.m....

Continue Reading
Rock Gate Buys Aviation Niche Player Blast Deflectors

Updated Category News Views 17

Jet exhaust is not glamorous, but somebody has to keep it from battering everything nearby. Rock Gate Partners’ acquisition of Blast Deflectors, Inc. puts money behind one of those stubbornly unsexy industrial niches where engineering credibility matters far more than a flashy sales pitch. The transaction closed October 16, 2026, and Northborne Partners announced...

Continue Reading
Hope Charities Makes Care Funding Easier to Track Online

Updated Category News Views 72

A treatment bill can wreck a household long before a diagnosis does. That is the uncomfortable reality behind Hope Charities' new Access to Care website, a centralized resource meant to show people in the bleeding disorders community when diagnosis-specific charitable assistance funds are available. This is not flashy technology, nor should it be treated like some grand...

Continue Reading

Top 5 Most Recently Viewed Articles

INTCO Medical Surges Ahead with 40.6% Revenue Boost

Updated Category News Views 94

Eying Growth: INTCO Medical's Impressive Revenue Surge In today's corporate world, a 40.6% revenue jump over a single half-year isn't something to sneeze at. INTCO Medical, a heavyweight in the disposable glove industry, has done exactly that. The whispers out of Zibo, China, hint at a company that’s firing on all cylinders with $1.03 billion in their pockets for the...

Continue Reading
Taylor Davis Joins Pivot Point Consulting to Boost Client Success

Updated Category News Views 108

Pivot Point Consulting brought in a big player back then: Taylor Davis, the former President of KLAS Research. He wasn't just some guy; he founded the KLAS Arch Collaborative. This move was about shaking things up in healthcare consulting during tough times. Desks were buzzing over this power shift. In his past gig at KLAS, Davis was instrumental in creating standards...

Continue Reading
Entegris' Financial Highlights and Outlook for 2025

Updated Category News Views 971

Entegris Reports Strong Fourth Quarter Performance Entegris, Inc. (NASDAQ: ENTG) has recently released its financial results marking a robust conclusion to the fiscal year. The company's fourth-quarter performance surpassed projections for both revenue and non-GAAP earnings per share. CEO Insights on Market Dynamics Bertrand Loy, the President and CEO of Entegris,...

Continue Reading
Top Dividend Stocks Insiders Increased Their Investments In January

Updated Category News Views 109

Insider Purchasing Trends in Dividend Stocks January unveiled strong insider buying activity across various dividend-paying stocks, pointing to confidence in future growth. Leaders in this buying spree were notable companies including Lakeland Industries (NASDAQ: LAKE), York Water (NASDAQ: YORW), and RLI Corp (NYSE: RLI). Such movements may indicate these stocks are worth...

Continue Reading
FDA Approves Omvoh for Crohn's Disease: A New Era in Treatment

Updated Category News Views 515

FDA Approves Omvoh for Crohn's Disease Eli Lilly and Company (NYSE: LLY) proudly announces the FDA's approval of Omvoh (mirikizumab-mrkz), a groundbreaking treatment for adults suffering from moderately to severely active Crohn's disease. This marks a significant advancement, as Omvoh is now recognized for treating not just this debilitating condition but also ulcerative...

Continue Reading